Industry News
Pharmaceutical Industry News
AstraZeneca weighs spinning out COVID-19 products into separate company: Bloomberg
AstraZeneca weighs spinning out COVID-19 products into separate company: Bloomberg aliu Mon, 12/06/2021 - 06:22
On Syria’s Ruins, a Drug Empire Flourishes
Powerful associates of Syria’s president, Bashar al-Assad, are making and selling captagon, an illegal amphetamine, creating a new narcostate on the Mediterranean.
The Variant Hunters: Inside South Africa’s Effort to Stanch Dangerous Mutations
Scientists in a cutting-edge laboratory do part of the work. Local health workers on foot do the rest.
In Africa, Dealing With Vaccine Challenges and the Omicron Variant
Vaccine shortages and skepticism, and rewarding countries for discovering variants. Also: Happiness and politics; unwanted children; beware of psychedelics.
In Africa, Dealing With Vaccine Challenges and the Omicron Variant
Vaccine shortages and skepticism, and rewarding countries for discovering variants. Also: Happiness and politics; unwanted children; beware of psychedelics.
Novartis’ Sandoz yanks one lot of deep vein thrombosis injectable after exposure to heat during shipping
Novartis' Sandoz yanks one lot of deep vein thrombosis injectable after exposure to heat during shipping fkansteiner Fri, 12/03/2021 - 12:44
November sees Sanofi-Regeneron dethroned after 6-month rule over top TV ad spender list
November sees Sanofi-Regeneron dethroned after 6-month rule over top TV ad spender list sharon.coey Fri, 12/03/2021 - 11:39
November sees Sanofi-Regeneron dethroned after 6-month rule over TV ad spender list
November sees Sanofi-Regeneron dethroned after 6-month rule over TV ad spender list sharon.coey Fri, 12/03/2021 - 11:39
Recordati to acquire EUSA Pharma for €750m, gaining 4 rare cancer drugs
Recordati to acquire EUSA Pharma for €750m, gaining 4 rare cancer drugs kdunleavy Fri, 12/03/2021 - 11:20
Bayer pads blockbuster case for Nubeqa with phase 3 win in metastatic prostate cancer
Bayer pads blockbuster case for Nubeqa with phase 3 win in metastatic prostate cancer fkansteiner Fri, 12/03/2021 - 10:52
Fierce Pharma Asia—China’s insulin price cut; Astellas-Dyno gene therapy deal; Fujifilm’s U.K. investment
Fierce Pharma Asia—China’s insulin price cut; Astellas-Dyno gene therapy deal; Fujifilm’s U.K. investment aliu Fri, 12/03/2021 - 10:10
BioNTech CEO Sahin urges calm amid omicron’s spread, figures new vaccine will eventually be needed for variant
BioNTech CEO Sahin urges calm amid omicron’s spread, figures new vaccine will eventually be needed for variant kdunleavy Fri, 12/03/2021 - 09:58
AstraZeneca blocks investor group’s $7.6B buyout of rare disease specialist Sobi: report
AstraZeneca blocks investor group's $7.6B buyout of rare disease specialist Sobi: report fkansteiner Fri, 12/03/2021 - 09:18
Biogen’s Spinraza, Fosun-Kite’s Yescarta and a controversial Alzheimer’s drug: All you need to know about China’s new state coverage
Biogen's Spinraza, Fosun-Kite's Yescarta and a controversial Alzheimer's drug: All you need to know about China's new state coverage aliu Fri, 12/03/2021 - 08:23
More growth on the way for CSL? Australian giant in talks to buy Vifor for $7.1B: report
More growth on the way for CSL? Australian giant in talks to buy Vifor for $7.1B: report kdunleavy Thu, 12/02/2021 - 14:44
Will High Vaccination Rates Help Spain Weather Omicron?
Spain surpassed others in Europe by avoiding politicized debate about Covid shots. Citizens also largely heeded the health guidance from their leaders.
Bristol Myers wrongfully denied exemption requests to COVID-19 vaccination policy, employees say in lawsuit
Bristol Myers wrongfully denied exemption requests to COVID-19 vaccination policy, employees say in lawsuit kdunleavy Thu, 12/02/2021 - 11:24
Fast-growing Real Chemistry names new CEO to lead agency’s digital transformation
Fast-growing Real Chemistry names new CEO to lead agency's digital transformation nmissakian Thu, 12/02/2021 - 10:37
Novartis CEO Narasimhan aims to surmount $9B patent cliff with 20 blockbuster launches
Novartis CEO Narasimhan aims to surmount $9B patent cliff with 20 blockbuster launches aliu Thu, 12/02/2021 - 10:25
Amgen’s Otezla notches win in genital psoriasis, snagging possible edge against forthcoming BMS rival
Amgen's Otezla notches win in genital psoriasis, snagging possible edge against forthcoming BMS rival fkansteiner Thu, 12/02/2021 - 10:02